TG Therapeutics, Inc.

Historical 13F Holders

Symbol
TGTX
CUSIP
88322Q108
All holders as of
Q4 2025
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q1 108 8.71 M $289 M
2025 Q4 371 81.4 M $2.43 B
2025 Q3 378 99.2 M $3.58 B
2025 Q2 390 102 M $3.68 B
2025 Q1 406 99.0 M $3.90 B
2024 Q4 365 97.2 M $2.93 B
2024 Q3 340 103 M $2.40 B
2024 Q2 287 95.5 M $1.71 B
2024 Q1 273 93.1 M $1.42 B
2023 Q4 272 94.1 M $1.61 B
2023 Q3 268 90.7 M $764 M
2023 Q2 286 88.4 M $2.19 B
2023 Q1 237 94.9 M $1.43 B
2022 Q4 226 104 M $1.23 B
2022 Q3 209 100 M $595 M
2022 Q2 200 106 M $454 M
2022 Q1 211 101 M $965 M
2021 Q4 228 102 M $1.93 B
2021 Q3 256 96.4 M $3.21 B
2021 Q2 263 96.2 M $3.73 B
2021 Q1 259 98.8 M $4.77 B
2020 Q4 277 100 M $5.23 B
2020 Q3 203 87.7 M $2.35 B
2020 Q2 198 84.0 M $1.63 B
2020 Q1 167 64.9 M $640 M
2019 Q4 159 59.3 M $658 M
2019 Q3 131 48.4 M $272 M
2019 Q2 142 50.4 M $436 M
2019 Q1 133 48.2 M $387 M
2018 Q4 129 49.6 M $204 M
2018 Q3 158 48.4 M $271 M
2018 Q2 151 40.8 M $536 M
2018 Q1 140 38.8 M $551 M
2017 Q4 118 35.8 M $293 M
2017 Q3 113 35.6 M $422 M
2017 Q2 115 34.3 M $345 M
2017 Q1 111 30.9 M $360 M
2016 Q4 97 21.8 M $101 M
2016 Q3 80 27.1 M $209 M
2016 Q2 94 29.1 M $178 M
2016 Q1 86 29.6 M $252 M
2015 Q4 93 26.9 M $321 M
2015 Q3 86 28.0 M $283 M
2015 Q2 94 23.9 M $396 M
2015 Q1 83 21.5 M $332 M
2014 Q4 80 18.7 M $296 M
2014 Q3 73 15.5 M $165 M
2014 Q2 74 13.1 M $123 M
2014 Q1 58 11.6 M $80.3 M